Former Hoosier Cancer Research Network vice chair Robin T. Zon, MD, FACP, FASCO, has been selected by the American Society of Clinical Oncology (ASCO) Nominating Committee as a candidate for president-elect. Dr. Zon (pictured left) is a vice president and senior partner at Michiana Hematology-Oncology, P.C. She served as HCRN vice chair from 2006 to 2009 and as chief community officer from 2009 to 2010. She has been a member of ASCO since 1997.

In addition, Maha H. A. Hussain, MD, FACP, FASCO, has been nominated for election to the Board of Directors. Dr. Hussain (pictured right) is associate director of clinical research at the University of Michigan Comprehensive Cancer Center, which is a member of Hoosier Cancer Research Network. She was instrumental in the formation of the Big Ten Cancer Research Consortium.

ASCO members are encouraged to vote in this year’s election. The ballot will be available for preview starting October 28, with voting beginning November 3. To vote, members will need their ASCO username and password.

For a full list of nominees, please see: http://connection.asco.org/magazine/society-member-news/society-announces-candidates-2016-asco-election/.

About Hoosier Cancer Research Network:

Hoosier Cancer Research Network (formerly known as Hoosier Oncology Group) conducts innovative cancer research in collaboration with academic and community physicians and scientists across the United States. The organization provides comprehensive clinical trial management and support, from conception through publication. Created in 1984 as a program of the Walther Cancer Institute, Hoosier Cancer Research Network became an independent nonprofit clinical research organization in 2007. Since its founding, Hoosier Cancer Research Network has initiated more than 150 trials in a variety of cancer types and supportive care, resulting in more than 300 publications. More than 4,600 subjects have participated in Hoosier Cancer Research Network clinical trials.